Recording: COVID-19: Strategic Implications for Biopharma
Tim Erlich participated in this panel alongside Locust Walk discussing COVID-19's strategic implications for biopharma. Listen to the recording here.
Insights
April 2, 2020
Tim Erlich participated in this panel alongside Locust Walk discussing COVID-19's strategic implications for biopharma. Listen to the recording here.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP
© 2024 Gunderson Dettmer; all rights reserved.
Back to top